104 related articles for article (PubMed ID: 2171218)
1. Virus envelope-based peptide vaccines against virus-induced mammary tumors.
Dion AS; Knittel JJ; Morneweck ST
Virology; 1990 Nov; 179(1):474-7. PubMed ID: 2171218
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice.
Girardi AJ; Dion AS; Pomenti AA; Holben JA
J Natl Cancer Inst; 1985 Feb; 74(2):405-13. PubMed ID: 2983136
[TBL] [Abstract][Full Text] [Related]
3. Expression and disposition of the murine mammary tumor virus (MuMTV) envelope gene products by murine mammary tumor cells.
Sarkar NH; Racevskis J
Virology; 1983 Apr; 126(1):279-300. PubMed ID: 6302986
[TBL] [Abstract][Full Text] [Related]
4. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains.
Girardi AJ; Dion AS; Holben JA
J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052
[TBL] [Abstract][Full Text] [Related]
5. Immunization of mice against murine mammary tumor virus infection and mammary tumor development.
Sarkar NH; Moore DH
Cancer Res; 1978 May; 38(5):1468-72. PubMed ID: 205366
[TBL] [Abstract][Full Text] [Related]
6. Effect of a mouse mammary tumor virus-derived protein vaccine on primary tumor development in mice.
Creemers P; Ouwehand J; Bentvelzen P
J Natl Cancer Inst; 1978 Jun; 60(6):1461-6. PubMed ID: 206711
[TBL] [Abstract][Full Text] [Related]
7. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
Lopez DM; Lopez PF; Parks WP; Paul RD
J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring humoral immunity to murine mammary tumor virus (MuMTV) and MuMTV GP52 in mice with low mammary tumor incidence.
Arthur LO; Fine DL
Int J Cancer; 1978 Dec; 22(6):734-40. PubMed ID: 214408
[No Abstract] [Full Text] [Related]
9. Immunization with a mouse mammary tumour virus envelope protein epitope protects against tumour formation without inhibition of the virus infection.
Astori M; Karapetian O
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1935-9. PubMed ID: 9266991
[TBL] [Abstract][Full Text] [Related]
10. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
Schochetman G; Arthur LO; Long CW; Massey RJ
J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
[TBL] [Abstract][Full Text] [Related]
11. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice.
McGrath CM; Prass WA; Maloney TM; Jones RF
J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of murine mammary tumor virus antibody and antigens in normal and tumor-bearing feral mice.
Fine DL; Arthur LO; Gardner MB
J Natl Cancer Inst; 1978 Aug; 61(2):485-91. PubMed ID: 210292
[TBL] [Abstract][Full Text] [Related]
13. An antigen cross-reactive with gp52 of mammary tumor virus is expressed on a B cell subpopulation of mice.
Tax A; Ewert D; Manson LA
J Immunol; 1983 May; 130(5):2368-71. PubMed ID: 6300244
[TBL] [Abstract][Full Text] [Related]
14. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors.
Michalides R; Wagenaar E; Nusse R
J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
Ritzi EM; Smith BA; Stolfi RL; Martin DS
Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of exogenous murine mammary tumor virus virulence in the C3H/HeJ mouse substrain bearing the Lps mutation.
Outzen HC; Corrow D; Shultz LD
J Natl Cancer Inst; 1985 Nov; 75(5):917-23. PubMed ID: 2997536
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
Lopez DM; Sigel MM; Charyulu VL
J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
[TBL] [Abstract][Full Text] [Related]
18. Failure to induce protection against transplanted mammary tumours by vaccination with the purified murine mammary tumour virus structural proteins gp52 and p28.
Creemers P; Westenbrink F; Brinkhof J; Bentvelzen P
Eur J Cancer (1965); 1979 May; 15(5):679-84. PubMed ID: 228941
[No Abstract] [Full Text] [Related]
19. Murine mammary tumor virus related antigen in human male mammary carcinoma.
Lloyd RV; Rosen PP; Sarkar NH; Jimenez D; Kinne DW; Menendez-Botet C; Schwartz MK
Cancer; 1983 Feb; 51(4):654-61. PubMed ID: 6295611
[TBL] [Abstract][Full Text] [Related]
20. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development.
Altrock BW; Cardiff RD; Blair PB
J Natl Cancer Inst; 1981 Jul; 67(1):163-8. PubMed ID: 6265680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
